Burioka N, Sasaki T
Third Department of Internal Medicine, Faculty of Medicine, Tottori University.
Nihon Rinsho. 1996 Nov;54(11):2956-61.
Several attempts have recently been made to develop chronotherapy for nocturnal asthma, using theophylline, inhaled corticosteroid, inhaled anticolinergic agent and beta 2-agonist. Pharmacological chronotherapy is the administration of medication according to biological rhythm to maximize pharmacological effects and minimize side effects. The circadian rhythm of biological rhythms is particularly important in understanding the declined changes in lung function of asthmatics at night. Since diurnal variations of PEF obtained from asthmatics, include circadian rhythms at a high rate, it is thought that PEF may be suitable for evaluating the effect of chronotherapy. Chronotherapy of a once-daily evening dose of a new controlled-release theophylline preparation, that achieves to peak blood concentrations at 10-12 hours after dosage, effectively improved the values of PEF and symptoms of nocturnal asthmatics. Hereafter, it is speculated that more effective therapy will be developed by using chronopharmacological designed drugs.
最近人们进行了几次尝试,使用茶碱、吸入性皮质类固醇、吸入性抗胆碱能药物和β2受体激动剂来开发针对夜间哮喘的时间疗法。药理学时间疗法是根据生物节律给药,以最大限度地提高药理作用并最小化副作用。生物节律的昼夜节律在理解哮喘患者夜间肺功能下降的变化方面尤为重要。由于哮喘患者的呼气峰流速(PEF)的日间变化包含较高比例的昼夜节律,因此认为PEF可能适合评估时间疗法的效果。一种每日一次的新型控释茶碱制剂,在给药后10 - 12小时达到血药浓度峰值,对其进行的时间疗法有效地改善了夜间哮喘患者的PEF值和症状。此后,推测通过使用时间药理学设计的药物将开发出更有效的治疗方法。